小智港股覆盤 | 8月30日
今日，港股三大指數集體下跌。截止收盤，恆生指數跌0.37%，報19949點。國企指數跌0.47%，報6840點。恆生科技指數跌0.51%，報4227點。市場約663只個股上漲，931只個股下跌。成交額突破961.38億港幣，和昨天同期相比增長4.74%。南下資金淨流出9235.54萬港幣。
盤面上，綜合消費服務板塊全線走強。新東方在線漲超26%；客思控股漲超21%；金匯教育漲超9%；澳洲成峯高教漲超8%；新東方-S漲超6%。中金：上調新東方在線評級至“跑贏行業”，目標價升至26港元；新東方-S尾盤漲超12%創年內新高，合共購回近2.56億美元債券。
航空貨運板塊跟隨走強。樂氏國際控股漲超13%；中國農業生態漲超12%；中通快遞-SW漲超3%；環宇物流(亞洲)、嘉裏物流等多股漲超1%。樂氏國際控股中期收益輕微減少約5.6%至9360萬元；中通快遞-SW：擬發售8.7億美元的可換股優先票據。
海運板塊走高。中遠海控漲超6%；東方海外國際漲超2%；勇利投資漲超1%。大摩：下調中遠海控評級至“與大市同步”，目標價下調至13.3港元。
建築建材板塊多數下跌。中國聯塑、洛陽玻璃股份等多股跌超5%；佳辰控股跌超4%；美亨實業跌超1%。佳辰控股料中期純利不多於850萬元人民幣。
醫療服務板塊走低。開拓藥業-B、北海康成-B等多股跌超13%；中國醫療網絡、創勝集團-B、諾輝健康-B等多股跌超6%；百濟神州、中國衛生集團-舊、永泰生物-B等多股跌超5%；海吉亞醫療、華檢醫療等多股跌超3%。開拓藥業中期虧損擴至5.18億人民幣；北海康成-B上半年營收大增184.84%，淨虧損收窄至2.49億元；創勝集團－Ｂ中期收入減少18.46%至2175.8萬元人民幣；百濟神州：預計2024年開始每年將有10+項IND申請。
醫療服務板塊走低。開拓藥業-B、北海康成-B等多股跌超13%；中國醫療網絡、創勝集團-B、諾輝健康-B等多股跌超6%；百濟神州、中國衛生集團-舊、永泰生物-B等多股跌超5%；海吉亞醫療、華檢醫療等多股跌超3%。開拓藥業中期虧損擴至5.18億人民幣；北海康成-B上半年營收大增184.84%，淨虧損收窄至2.49億元；創勝集團－Ｂ中期收入減少18.46%至2175.8萬元人民幣；百濟神州：預計2024年開始每年將有10+項IND申請。
uSMART智能寫手的信息、數據均來自媒體公開報道，智能寫手不能保證其完全準確，內容僅供參考，不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
